Androgenetic Alopecia Treatment Market
According to Intent Market Research, the Androgenetic Alopecia Treatment Market is expected to grow from USD 3.7 Billion in 2024-e at a CAGR of 8.7% to touch USD 6.6 Billion by 2030. The Androgenetic Alopecia Treatment Market is dominated by key players such as, Aclaris Therapeutics, Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Bausch Health Companies Inc., Revance Therapeutics, Inc., and Cipla Ltd..